These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 18562429

  • 21. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D, Cox BJ, Bradwejn J.
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [Abstract] [Full Text] [Related]

  • 22. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell'Osso L.
    J Affect Disord; 2008 Jan; 105(1-3):279-83. PubMed ID: 17553570
    [Abstract] [Full Text] [Related]

  • 23. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety.
    Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, Oude Voshaar RC, Elzinga BM.
    World J Biol Psychiatry; 2012 Oct; 13(7):535-43. PubMed ID: 21888560
    [Abstract] [Full Text] [Related]

  • 24. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Oct; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 25. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: no effects on brain-derived neurotrophic factor (BDNF) concentrations in serum.
    Lang UE, Hellweg R, Gallinat J, Bajbouj M.
    J Affect Disord; 2008 Apr; 107(1-3):255-8. PubMed ID: 17825920
    [Abstract] [Full Text] [Related]

  • 26. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?
    Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H, Ueda N, Nakamura J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):679-85. PubMed ID: 18160197
    [Abstract] [Full Text] [Related]

  • 27. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Apr 01; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 28. Serum brain-derived neurotrophic factor in patients with trauma psychopathology.
    Hauck S, Kapczinski F, Roesler R, de Moura Silveira E, Magalhães PV, Kruel LR, Schestatsky SS, Ceitlin LH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):459-62. PubMed ID: 20097247
    [Abstract] [Full Text] [Related]

  • 29. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul 16; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects.
    Chan KL, Tong KY, Yip SP.
    Neurosci Lett; 2008 Dec 12; 447(2-3):124-8. PubMed ID: 18852019
    [Abstract] [Full Text] [Related]

  • 32. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D, Copen J, Bradwejn J.
    J Affect Disord; 2004 Jun 12; 80(2-3):285-90. PubMed ID: 15207943
    [Abstract] [Full Text] [Related]

  • 33. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 12; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity.
    Lang UE, Hellweg R, Seifert F, Schubert F, Gallinat J.
    Biol Psychiatry; 2007 Sep 01; 62(5):530-5. PubMed ID: 17560556
    [Abstract] [Full Text] [Related]

  • 37. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct 01; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 38. Maternal serum concentrations of BDNF and depression in the perinatal period.
    Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Höppner J, Virchow JC.
    Psychoneuroendocrinology; 2006 Apr 01; 31(3):388-94. PubMed ID: 16289360
    [Abstract] [Full Text] [Related]

  • 39. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL.
    Neurosci Lett; 2008 Jul 11; 439(2):157-9. PubMed ID: 18514407
    [Abstract] [Full Text] [Related]

  • 40. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences.
    Piccinni A, Marazziti D, Del Debbio A, Bianchi C, Roncaglia I, Mannari C, Origlia N, Catena Dell'Osso M, Massimetti G, Domenici L, Dell'Osso L.
    Chronobiol Int; 2008 Sep 11; 25(5):819-26. PubMed ID: 18780207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.